TOMI Environmental Solutions, Inc. (TOMZ) AI Stock Analysis

NASDAQ: TOMZAI research summary: business, growth, valuation, analysts, bull and bear case.

TOMZ AI stock analysis summary

AI Research

TOMI Environmental Solutions, Inc. (TOMZ) provides indoor surface decontamination systems using its Binary Ionization Technology. The company generated $6.9M in trailing twelve-month revenue with a net profit margin of -49.8%. While quarterly revenue jumped 117.9% year-over-year in the period ended June 30, 2026, the company holds $321,899 in cash against $3.4M in total debt.

Market cap
$14.4M
Revenue (TTM)
$6.9M
P/E
—
fwd 12.0x
1Y return
-48.4%
S&P 500 16.8%
Avg. target
$7.00
376.2% vs last close

Bull case

  • Quarterly revenue growth expanded by 117.9% year-over-year for the period ended June 30, 2026.
  • Analyst consensus projects fiscal year 2026 revenue of $11.9M and fiscal year 2027 revenue of $18.2M, representing 52.2% growth.
  • The stock trades at a forward P/E of 12.0x, which is lower than the US-listed Industrials peer median of 17.2x.

Bear case

  • The company posted negative free cash flow of -$1.3M in FY2025 and held only $321,899 in cash as of June 30, 2026.
  • Revenue declined at a -25.8% CAGR from FY2020 through FY2025, falling to $5.6M in FY2025.
  • Total debt stands at $3.4M against $1.4M in shareholders' equity, resulting in a high debt-to-equity ratio of 2.38.

What TOMI Environmental Solutions does

TOMI Environmental Solutions, Inc. provides environmental solutions for indoor surface decontamination across the United States and internationally. Its flagship products include the SteraMist Surface Unit, SteraMist Environment System, and SteraMist Hospital Disinfection Cart. It also offers the SteraMist Select Surface Unit, the Stainless Steel 90-Degree Applicator, the iHP Plasma Decontamination Chamber, the SteraMist Custom Engineered System, and iHP Corporate Service Decontamination. These systems use Binary Ionization Technology (BIT), a hydrogen peroxide-based mist and fog for bacteria decontamination and infectious disease control. Markets served include hospitals, bio-safety labs, pharmaceutical plants, food processing facilities, universities, and commercial settings.

Growth and profitability

TOMI experienced a 5-year revenue CAGR of -25.8% between FY2020 and FY2025. Annual revenue decreased from $7.8M in FY2021 to $5.6M in FY2025, with revenue falling 27.2% in FY2025. Gross margin was 54.6% in FY2025, while operating margin was -68.4% and net income was -$3.7M. Net income has remained negative across all reported years, including -$4.4M in FY2021, -$2.9M in FY2022, -$3.4M in FY2023, and -$4.5M in FY2024. For the trailing twelve months, revenue was $6.9M with EPS of -$0.50. However, the latest quarter ended June 30, 2026, saw quarterly revenue growth of 117.9% year-over-year.

TOMZ income statement →

Balance sheet and cash flow

As of June 30, 2026, TOMI had $321,899 in cash and short-term investments alongside total debt of $3.4M, resulting in net debt of $3.1M. Shareholders' equity was $1.4M against total assets of $8.4M. The company had a current ratio of 1.49 and a debt-to-equity ratio of 2.38. In FY2025, operating cash flow was -$1.2M and free cash flow was -$1.3M, while capital expenditures totaled $135,577. The company's share count increased 15.8% over the trailing 5-year period.

TOMZ balance sheet →

Valuation and performance

With a market cap of $14.4M and an enterprise value of $14.8M, TOMI trades at a forward P/E of 12.0x, compared to 17.2x for the median of its US-listed Industrials peers. Its price-to-sales ratio is 2.1x, above the peer median of 1.5x, and its EV-to-revenue multiple is 2.1x. Over the past year, the stock fell 48.4%, while the SPY S&P 500 benchmark gained 16.8%. Over five years, the stock dropped 65.2% compared to an 83.0% gain for the SPY.

TOMZ key metrics →

What analysts expect

Wall Street coverage includes 1 Strong Buy rating, with 0 Buy, Hold, Sell, or Strong Sell ratings. The mean price target is $7.00, which is 376.2% above the last closing price of $1.47 on October 16, 2026. For the current fiscal year ending December 31, 2026, consensus estimates project an EPS of -$0.07 on revenue of $11.9M. For the next fiscal year, the single analyst covering the stock expects EPS of $0.12 on $18.2M in revenue. The company beat EPS estimates in 1 of the last 4 quarters. The next earnings date is November 13, 2026.

TOMZ forecast and price target →

Key risks and what to watch

  • Liquidity risk is elevated given the cash balance of $321,899 relative to net debt of $3.1M and negative operating cash flow.
  • Share dilution has occurred, with the 5-year share count expanding by 15.8%.
  • Stock price volatility is significant, evidenced by a high beta of 1.95 and a 1-year return of -48.4%.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this TOMZ AI stock analysis

This page is an AI-written research summary of TOMI Environmental Solutions, Inc. (TOMZ). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: TOMZ income statement, TOMZ balance sheet, TOMZ key metrics, TOMZ analyst forecast, TOMZ chart. See the TOMZ stock overview for the latest quote and news.

TOMZ AI stock analysis FAQ

What does TOMI Environmental Solutions do?

TOMI Environmental Solutions provides bacteria decontamination and infectious disease control systems. Its core offerings include the SteraMist product line, which uses Binary Ionization Technology (BIT) to disinfect indoor spaces across healthcare, life sciences, and commercial industries.

Is TOMZ profitable?

No, TOMI is currently unprofitable. For FY2025, it reported a net loss of -$3.7M, and its trailing twelve months net profit margin was -49.8% with an EPS of -$0.50.

What is the analyst target price for TOMZ?

The single analyst tracking the company has a mean price target of $7.00, which is 376.2% above its last close of $1.47 on October 16, 2026.

Does TOMZ pay a dividend?

No, TOMI Environmental Solutions does not pay a dividend.

When is the next earnings release for TOMZ?

The next earnings date is scheduled for November 13, 2026.

More Industrials AI stock analysis